Kangmei Pharmaceutical Co Ltd banner

Kangmei Pharmaceutical Co Ltd
SSE:600518

Watchlist Manager
Kangmei Pharmaceutical Co Ltd Logo
Kangmei Pharmaceutical Co Ltd
SSE:600518
Watchlist
Price: 1.88 CNY -0.53% Market Closed
Market Cap: ¥26B

Wall Street
Price Targets

Price Targets Summary
Kangmei Pharmaceutical Co Ltd

There are no price targets for Kangmei Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kangmei Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for Kangmei Pharmaceutical Co Ltd's revenue is -1%. The projected CAGR for the next 6 years is 36%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

-31% / Year
Past Growth
241% / Year
Estimated Growth
Estimates Accuracy
-68%
Average Miss
-31% / Year
Past Growth
241% / Year
Estimated Growth
Estimates Accuracy
-68%
Average Miss

For the last 13 years the compound annual growth rate for Kangmei Pharmaceutical Co Ltd's net income is -31%. The projected CAGR for the next 6 years is 241%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kangmei Pharmaceutical Co Ltd's stock price target?
Not Available

Kangmei Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Kangmei Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
36%

For the last 13 years the compound annual growth rate for Kangmei Pharmaceutical Co Ltd's revenue is -1%. The projected CAGR for the next 6 years is 36%.

What is Kangmei Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
241%

For the last 13 years the compound annual growth rate for Kangmei Pharmaceutical Co Ltd's net income is -31%. The projected CAGR for the next 6 years is 241%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett